Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,600 | 1 | 95.2% |
| Food and Beverage | $362.75 | 20 | 4.5% |
| Entertainment | $19.73 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | $7,660 | 5 | $0 (2017) |
| Genentech USA, Inc. | $112.48 | 7 | $0 (2022) |
| Optos, Inc. | $84.72 | 4 | $0 (2020) |
| Alimera Sciences, Inc. | $40.67 | 2 | $0 (2017) |
| Mallinckrodt LLC | $23.86 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $20.85 | 1 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $19.92 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $19.88 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $24.48 | 1 | Genentech USA, Inc. ($24.48) |
| 2020 | $59.46 | 3 | Optos, Inc. ($38.61) |
| 2019 | $52.58 | 3 | Novartis Pharmaceuticals Corporation ($19.88) |
| 2018 | $96.86 | 5 | Genentech USA, Inc. ($26.70) |
| 2017 | $7,749 | 10 | Johnson & Johnson Surgical Vision, Inc. ($7,660) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/16/2020 | Optos, Inc. | P200DTx (Device), P200T, P200TE | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/15/2020 | Optos, Inc. | P200DTx (Device), P200T, P200TE | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/14/2020 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/30/2019 | OPTOS, INC. | P200DTx (Device), P200T, P200TE | Entertainment | Cash or cash equivalent | $19.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 02/27/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Ophthalmology | ||||||
| 12/06/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Ophthalmology | ||||||
| 10/29/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Ophthalmology | ||||||
| 09/05/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VISUDYNE (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/08/2018 | OPTOS, INC. | Monaco (Device), P200T, California | Food and Beverage | Cash or cash equivalent | $26.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/22/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 12/13/2017 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Ophthalmology | ||||||
| 12/07/2017 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: Ophthalmology | ||||||
| 11/01/2017 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Ophthalmology | ||||||
| 10/04/2017 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Ophthalmology | ||||||
| 05/16/2017 | Alimera Sciences, Inc. | Iluvien (Biological) | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: Ophthalmology | ||||||
| 04/21/2017 | Johnson & Johnson Surgical Vision, Inc. | Tecnis 1-piece IOL (Device), Tecnis Multifocal family of 1-piece IOLs, Tecnis Toric 1-piece IOL | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Optics | ||||||
| 02/07/2017 | Johnson & Johnson Surgical Vision, Inc. | Tecnis 1-piece IOL (Device), Tecnis Multifocal family of 1-piece IOLs, Tecnis Toric 1-piece IOL | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Optics | ||||||
| 02/07/2017 | Johnson & Johnson Surgical Vision, Inc. | Tecnis 1-piece IOL (Device), Tecnis Multifocal family of 1-piece IOLs, Tecnis Toric 1-piece IOL | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Optics | ||||||
| 02/07/2017 | Johnson & Johnson Surgical Vision, Inc. | Tecnis 1-piece IOL (Device), Tecnis Multifocal family of 1-piece IOLs, Tecnis Toric 1-piece IOL | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: Optics | ||||||
| 01/26/2017 | Johnson & Johnson Surgical Vision, Inc. | Tecnis 1-piece IOL (Device), Tecnis Multifocal family of 1-piece IOLs, Tecnis Toric 1-piece IOL | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
| Category: Optics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 16 | 3,168 | 9,042 | $5.2M | $1.5M |
| 2021 | 17 | 3,186 | 8,960 | $5.0M | $1.5M |
| 2020 | 17 | 3,272 | 7,635 | $4.0M | $1.2M |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 102 | 792 | $1.6M | $567,640 | 35.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 97 | 1,698 | $1.2M | $377,764 | 31.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 773 | 1,259 | $305,937 | $135,249 | 44.2% |
| 67028 | Injection of drug into eye | Office | 2022 | 247 | 934 | $685,470 | $96,186 | 14.0% |
| 92134 | Imaging of retina | Office | 2022 | 996 | 2,504 | $703,624 | $89,994 | 12.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 318 | 1,045 | $180,785 | $80,893 | 44.7% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 26 | 30 | $131,640 | $25,600 | 19.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 163 | 163 | $46,781 | $20,180 | 43.1% |
| 67041 | Removal of membrane of retina | Facility | 2022 | 12 | 12 | $89,448 | $13,233 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 100 | 100 | $30,200 | $12,505 | 41.4% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 11 | 33 | $85,305 | $10,779 | 12.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 55 | 145 | $23,200 | $10,624 | 45.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 102 | 158 | $41,870 | $6,707 | 16.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 43 | 43 | $20,683 | $5,290 | 25.6% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2022 | 21 | 23 | $35,650 | $4,815 | 13.5% |
| 92250 | Photography of the retina | Office | 2022 | 102 | 103 | $44,084 | $2,810 | 6.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 87 | 784 | $1.6M | $578,334 | 37.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2021 | 93 | 1,658 | $1.1M | $420,978 | 37.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 768 | 1,362 | $324,954 | $149,740 | 46.1% |
| 67028 | Injection of drug into eye | Office | 2021 | 243 | 929 | $680,360 | $98,271 | 14.4% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 826 | 2,234 | $627,754 | $83,178 | 13.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 333 | 988 | $166,946 | $80,130 | 48.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 197 | 197 | $57,658 | $27,195 | 47.2% |
| 67036 | Removal of eye fluid (vitreous) between the lens and retina | Facility | 2021 | 17 | 19 | $94,878 | $16,895 | 17.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2021 | 68 | 163 | $24,400 | $12,258 | 50.2% |
About Dr. Patrick Monahan, MD
Dr. Patrick Monahan, MD is a Specialist healthcare provider based in Campbell, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891783148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Monahan, MD has received a total of $7,982 in payments from pharmaceutical and medical device companies, with $24.48 received in 2022. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($7,600).
As a Medicare-enrolled provider, Monahan has provided services to 9,626 Medicare beneficiaries, totaling 25,637 services with total Medicare billing of $4.1M. Data is available for 3 years (2020–2022), covering 50 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Campbell, CA
- Active Since 10/11/2005
- Last Updated 08/11/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1891783148
Products in Payments
- Tecnis 1-piece IOL (Device) $7,660
- Lucentis (Biological) $88.00
- P200DTx (Device) $58.34
- Monaco (Device) $26.38
- VABYSMO (Drug) $24.48
- ACTHAR (Biological) $23.86
- Iluvien (Biological) $22.72
- EYLEA (Biological) $20.85
- VISUDYNE (Drug) $19.92
- Iluvien (Drug) $17.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Campbell
Dr. Polyxene Kokinos, Md, MD
Specialist — Payments: $28,224
R. Laurence Berkowitz, M.d, M.D
Specialist — Payments: $10,692
Dr. Sarah Lee, M.d, M.D
Specialist — Payments: $613.62
Felicia Radu-Radulescu, M.d, M.D
Specialist — Payments: $185.71
Dr. Khalil Fattahi, M.d, M.D
Specialist
James Duncan
Specialist